tradingkey.logo
tradingkey.logo
Search

Perspective Therapeutics Inc

CATX
Add to Watchlist
0.943USD
+0.101+12.00%
Close 11-13 16:00(ET)
107.64MMarket Cap
LossP/E TTM
After-hours 18:30 (ET)0.943USD-0.010-1.05%

Today

+12.00%

5 Days

+12.26%

1 Month

-59.70%

6 Months

-75.51%

Year to Date

-65.71%

1 Year

-54.66%

Key Figures

0.858Open
0.961High
549.08KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.48%Turnover Ratio
0.842Prev. Close
0.825Low
510.37KTurnover
LossP/E Static
0.37P/B
0.00%Div Yield TTM
-30.17%ROA
6.16052wk High
0.10Volume Ratio
-79.28MNet Profit
114.15MShares
-1.3986EPS TTM
1.74Beta
-35.33%ROE
0.78052wk Low
16.15%Amplitude
100.00%Gross Margin
107.64MMarket Cap
1.47Reward/Risk
7.03%Risk Rate
More news coming soon, stay tuned...

Perspective Therapeutics Inc's Score

0.05vs previous score
Forecast8.27
Financial Health5.64
Technical6.89
Valuation Dimensions8.25
Institutional Confidence5.00
Risk Assessment2.66

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
10.571Target Price
+819.25%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy33222222
Buy1111111111111111
Hold11111111
Sell00000000
Strong Sell00000000

Perspective Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.27/-0.25
Revenue / Forecast
20.00K/51.92K

Perspective Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolCATX
Number of employees138
CountryUnited States of America

Ownership

ShareholdersProportion
Lantheus Holdings, Inc.10.24%
TCG Crossover Management, LLC6.94%
Qatar Investment Authority6.20%
Commodore Capital LP5.56%
Shareholder TypesProportion
Investment Advisor22.02%
Hedge Fund16.81%
Corporation10.24%
Sovereign Wealth Fund6.20%

FAQs

What is the current price of Perspective Therapeutics Inc (CATX)?

The current price of Perspective Therapeutics Inc (CATX) is 0.94.

What is the symbol of Perspective Therapeutics Inc?

The ticker symbol of Perspective Therapeutics Inc is CATX.

What is the 52-week high of Perspective Therapeutics Inc?

The 52-week high of Perspective Therapeutics Inc is 6.16.

What is the 52-week low of Perspective Therapeutics Inc?

The 52-week low of Perspective Therapeutics Inc is 0.78.

What is the market capitalization of Perspective Therapeutics Inc?

The market capitalization of Perspective Therapeutics Inc is 107.64M.

Is Perspective Therapeutics Inc (CATX) currently rated as Buy, Hold, or Sell?

According to analysts, Perspective Therapeutics Inc (CATX) has an overall rating of Buy, with a price target of 10.57.

What is the Earnings Per Share (EPS TTM) of Perspective Therapeutics Inc (CATX)?

The Earnings Per Share (EPS TTM) of Perspective Therapeutics Inc (CATX) is -1.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.